Elderly idiopathic pulmonary fibrosis patients remain on therapy despite higher incidence of adverse events and dose reductions

Aykut Cilli,Nesrin Ocal,Fatih Uzer,Funda Coskun,Can Sevinc,Ahmet Ursavas,Pınar Yıldız,Pelin Pınar Deniz,Nilgün Yılmaz Demirci, Gamze Ozbey,Ahmet Yurttas,Ismail Hanta

Respiratory Investigation（2023）

引用 2|浏览3

暂无评分

摘要

The present study showed that elderly IPF patients experienced significantly increased AEs and dose reductions due to antifibrotic use, while the discontinuation rates of the drugs were similar to those of drugs used by non-elderly patients.

查看译文

关键词

idiopathic pulmonary fibrosis,pulmonary fibrosis,elderly

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要